日本語
 
Help Privacy Policy ポリシー/免責事項
  詳細検索ブラウズ

アイテム詳細

登録内容を編集ファイル形式で保存
一時保存へ追加
 タグ情報を表示リリース履歴を表示詳細要約
  Acetylcysteine for prevention of contrast nephropathy: meta-analysis

Birck, R., Krzossok, S., Markowetz, F., Schnulle, P., van der Woude, F. J., & Braun, C. (2003). Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet, 362(9384), 598-603.

Item is

 

表示: 全項目 非表示: 全項目

基本情報

表示: 非表示:
アイテムのパーマリンク: https://hdl.handle.net/11858/00-001M-0000-0010-89C8-5 版のパーマリンク: https://hdl.handle.net/11858/00-001M-0000-0010-89C9-3
資料種別: 学術論文
その他のタイトル : Lancet

ファイル

表示: ファイル

関連URL

表示:

作成者

表示:
非表示:
 作成者:
Birck, Rainer, 著者
Krzossok, Stefan, 著者
Markowetz, Florian1, 著者
Schnulle, Peter, 著者
van der Woude, Fokko J., 著者
Braun, Claude, 著者
所属:
1Max Planck Society, ou_persistent13              

内容説明

表示:
非表示:
キーワード: -
 要旨: Background Contrast nephropathy is associated with increased in-hospital morbidity and mortality and leads to extension of hospital stay in patients with chronic renal insufficiency. Acetylcysteine seems to be a safe and inexpensive way to reduce contrast nephropathy. We aimed to assess the efficacy of acetylcysteine to prevent contrast nephropathy after administration of radiocontrast media in patients with chronic renal insufficiency. Methods We did a meta-analysis of randomised controlled trials comparing acetylcysteine and hydration with hydration alone for preventing contrast nephropathy in patients with chronic renal insufficiency. The trials were identified through a combined search of the BIOSIS+/RRM, MEDLINE, Web of Science, Current Contents Medizin, and The Cochrane Library Databases. We used incidence of contrast nephropathy 48 h after administration of radiocontrast media as an outcome measure. Findings Seven trials including 805 patients were eligible according to our inclusion criteria and were analysed. Overall incidence of contrast nephropathy varied between 8% and 28%. Since significant heterogeneity was indicated by the Q statistics (p=0·016) we used a random-effects model to combine the data. Compared with periprocedural hydration alone, administration of acetylcysteine and hydration significantly reduced the relative risk of contrast nephropathy by 56% (0·435 [95% CI 0·215–0·879], P=0·02) in patients with chronic renal insufficiency. Meta-regression revealed no significant relation between the relative risk of contrast nephropathy and the volume of radiocontrast media administered or the degree of chronic renal insufficiency before the procedure. Interpretation Compared with periprocedural hydration alone, acetylcysteine with hydration significantly reduces the risk of contrast nephropathy in patients with chronic renal insufficiency. The relative risk of contrast nephropathy was not related to the amount of radiocontrast media given or to the degree of chronic renal insufficiency before the procedure.

資料詳細

表示:
非表示:
言語: eng - English
 日付: 2003-08-23
 出版の状態: 出版
 ページ: -
 出版情報: -
 目次: -
 査読: -
 識別子（DOI, ISBNなど）: eDoc: 173616
ISI: 000184904100007
 学位: -

関連イベント

表示:

訴訟

表示:

Project information

表示:

出版物 1

表示:
非表示:
出版物名: Lancet
  出版物の別名 : Lancet
種別: 学術雑誌
 著者・編者:
所属:
出版社, 出版地: -
ページ: - 巻号: 362 (9384) 通巻号: - 開始・終了ページ: 598 - 603 識別子（ISBN, ISSN, DOIなど）: ISSN: 0140-6736